PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy

Published:2022-06 Issue: Volume:346 Page:226-239
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kim Suyeon,Heo Roun,Song Seok Ho,Song Kwon-Ho,Shin Jung Min,Oh Se Jin,Lee Hyo-Jung,Chung Jo Eun,Park Jae Hyung,Kim Tae Woo

Funder

National Assembly of the Republic of Korea

Ministry of Health and Welfare

National Research Foundation of Korea

Korea Drug Development Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference71 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Mechanisms of cancer resistance to immunotherapy;Bai;Front. Oncol.,2020

3. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat Rev Immunol,2020

4. Neoantigen vaccine: an emerging tumor immunotherapy;Peng;Mol. Cancer,2019

5. A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo;Lee;J. Control. Release,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncationic polymer-assisted carrier for nucleic acid drug delivery;Science China Materials;2024-08-15

2. Targeting pediatric solid tumors in the new era of RNA therapeutics;Critical Reviews in Oncology/Hematology;2024-08

3. Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy;International Journal of Biological Macromolecules;2024-07

4. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy;ACS Nano;2024-06-05

5. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3